当前位置: 首页 >> 检索结果
62. New metrics for the Lancet Standing Commission on Liver Disease in the UK.
作者: Roger Williams.;Graeme Alexander.;Richard Aspinall.;Joanne Bosanquet.;Ginette Camps-Walsh.;Matthew Cramp.;Natalie Day.;Anil Dhawan.;John Dillon.;Jessica Dyson.;James Ferguson.;Graham Foster.;Richard Gardner.;Sir Ian Gilmore.;Lesley Hardman.;Mark Hudson.;Deirdre Kelly.;Andrew Langford.;Stephen Liversedge.;Kieran Moriarty.;Philip Newsome.;John O'Grady.;Rachel Pryke.;Liz Rolfe.;Harry Rutter.;Stephen Ryder.;Marianne Samyn.;Nick Sheron.;Alison Taylor.;Jeremy Thompson.;Julia Verne.;Andrew Yeoman.
来源: Lancet. 2017年389卷10083期2053-2080页 64. Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial.
作者: Abhijit Nadkarni.;Benedict Weobong.;Helen A Weiss.;Jim McCambridge.;Bhargav Bhat.;Basavaraj Katti.;Pratima Murthy.;Michael King.;David McDaid.;A-La Park.;G Terence Wilson.;Betty Kirkwood.;Christopher G Fairburn.;Richard Velleman.;Vikram Patel.
来源: Lancet. 2017年389卷10065期186-195页
Although structured psychological treatments are recommended as first-line interventions for harmful drinking, only a small fraction of people globally receive these treatments because of poor access in routine primary care. We assessed the effectiveness and cost-effectiveness of Counselling for Alcohol Problems (CAP), a brief psychological treatment delivered by lay counsellors to patients with harmful drinking attending routine primary health-care settings.
65. The Healthy Activity Program (HAP), a lay counsellor-delivered brief psychological treatment for severe depression, in primary care in India: a randomised controlled trial.
作者: Vikram Patel.;Benedict Weobong.;Helen A Weiss.;Arpita Anand.;Bhargav Bhat.;Basavraj Katti.;Sona Dimidjian.;Ricardo Araya.;Steve D Hollon.;Michael King.;Lakshmi Vijayakumar.;A-La Park.;David McDaid.;Terry Wilson.;Richard Velleman.;Betty R Kirkwood.;Christopher G Fairburn.
来源: Lancet. 2017年389卷10065期176-185页
Although structured psychological treatments are recommended as first-line interventions for depression, only a small fraction of people globally receive these treatments because of poor access in routine primary care. We assessed the effectiveness and cost-effectiveness of a brief psychological treatment (Healthy Activity Program [HAP]) for delivery by lay counsellors to patients with moderately severe to severe depression in primary health-care settings.
66. Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
作者: Séverine Vermeire.;Stefan Schreiber.;Robert Petryka.;Tanja Kuehbacher.;Xavier Hebuterne.;Xavier Roblin.;Maria Klopocka.;Adrian Goldis.;Maria Wisniewska-Jarosinska.;Andrey Baranovsky.;Robert Sike.;Kremena Stoyanova.;Chantal Tasset.;Annegret Van der Aa.;Pille Harrison.
来源: Lancet. 2017年389卷10066期266-275页
Filgotinib (GLPG0634, GS-6034) is a once-daily, orally administered, Janus kinase 1 (JAK1)-selective inhibitor. The FITZROY study examined the efficacy and safety of filgotinib for the treatment of moderate-to-severe Crohn's disease.
68. Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study.
作者: Paul D Griffiths.;Michael Bradburn.;Michael J Campbell.;Cindy L Cooper.;Ruth Graham.;Deborah Jarvis.;Mark D Kilby.;Gerald Mason.;Cara Mooney.;Stephen C Robson.;Allan Wailoo.; .
来源: Lancet. 2017年389卷10068期538-546页
In-utero MRI (iuMRI) has shown promise as an adjunct to ultrasound but the comparative diagnostic performance has been poorly defined. We aimed to assess whether the diagnostic accuracy and confidence of the prenatal diagnosis of fetal brain abnormalities is improved with iuMRI and assess the clinical impact and patient acceptability of iuMRI.
|